MAPT and Alzheimer disease: Though originally the staging of tau accumulation in AD was performed using staining methods and immunohistochemistry, with the advancement of neuroimaging techniques it is possible to discern a pattern for the distribution of tau in vivo using positron emission tomography (PET) tracers (Okamura et al., 2018; Villemagne et al., 2015).